☆ 4.5 Article

Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosis

JHEP REPORTS (2022)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

The COVID-19 Pandemic Highlights Opportunities to Improve Hepatocellular Carcinoma Screening and Diagnosis in a National Health System

Nicole J. Kim et al.

Summary: The COVID-19 pandemic has had a negative impact on HCC screening and diagnosis rates in the Veterans Health Administration, with a significant decline in screening rates. In terms of diagnosis, a decline was observed only for patients with Model for End Stage Liver Disease-Sodiumscore <20 or Fibrosis-4 score <3.25.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Add to Collection

Letter Gastroenterology & Hepatology

Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic

Sasha Deutsch-Link et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

Thomas Marjot et al.

Summary: This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19. Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review

Jenny Lee et al.

Summary: This study synthesized the existing literature on the ability of FIB-4, NFS, and APRI models in prognosticating NAFLD-related events. The results showed that these models have demonstrated good ability to risk stratify patients for liver-related morbidity and mortality, with inconsistent performance in predicting change in fibrosis stage. Further head-to-head studies are needed to validate their performance and refine models for prognosticating NAFLD events.

LIVER INTERNATIONAL (2021)

Add to Collection

Article Gastroenterology & Hepatology

Massive impact of coronavirus disease 2019 pandemic on gastroenterology and hepatology departments and doctors in Spain

Javier Crespo et al.

Summary: This study assessed the impact of the COVID-19 pandemic on gastroenterology and hepatology departments and specialists in Spain, revealing a significant reduction in outpatient visits and procedures. The high prevalence of infection among gastroenterologists suggests the need for regular SARS-CoV-2 screening and adequate protection measures to be maintained.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

Yana Davidov-Derevynko et al.

Summary: COVID-19 infection is associated with liver impairment in a significant number of patients, with mild abnormalities being more common. Higher FIB-4 levels upon admission are related to increased mortality, and patients with preexisting liver disease have a higher risk of death compared to those without liver disease.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

Arun J. Sanyal et al.

Summary: In this study involving patients with nonalcoholic fatty liver disease, advanced fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death over a median of 4 years of follow-up. Advanced fibrosis was also related to an increased incidence of liver decompensation events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Gastroenterology & Hepatology

Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature

Riccardo De Carlis et al.

Summary: The COVID-19 pandemic has significantly impacted liver transplantation programs globally, requiring administrators to make difficult decisions balancing risk and life-saving procedures. Different centers have implemented various measures to prevent transmission, but further assessment and research are needed to fully understand the impact.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives

Hung-Yuan Su et al.

Summary: Patients with cirrhosis are more susceptible to viral infection due to dysregulated immune response. COVID-19-related liver injury in cirrhotic patients can be attributed to various factors, leading to high rates of morbidity and mortality. Respiratory failure is the main cause of death in cirrhotic patients with COVID-19, with a significant proportion lacking initial respiratory symptoms.

WORLD JOURNAL OF CLINICAL CASES (2021)

Add to Collection

Article Medicine, General & Internal

Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver

Harshitha Shanmugam et al.

Summary: The study found that people in Europe generally gained weight during the lockdown period, with higher weight gain observed in Italy. Those with no physical activity and low adherence to the Mediterranean diet had a higher increase in body weight. Strict social containment measures may increase the risk of metabolic abnormalities in the medium to long term.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Review Medicine, General & Internal

Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050

Angela E. Micah et al.

Summary: Global health spending is expected to continue to grow, but remain unequally distributed between countries. In 2020, we estimate that development organisations substantially increased the amount of development assistance for health provided. Continued efforts are needed to raise sufficient resources to mitigate the pandemic for the most vulnerable, and to help curtail the pandemic for all.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease

Kazunori Kawaguchi et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is associated with serious complications, and changes in liver function reserves and albumin levels may indicate the occurrence of NAFLD-related serious events. Decreases in serum albumin concentration could potentially serve as a surrogate marker for predicting these events.

MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic

Stephanie Baggio et al.

Summary: The study found that 38.5% of patients reported forgoing health care, with younger patients, women, patients with a low level of education, and patients with chronic diseases being more likely to do so. No significant association was found between the presence of anti-SARS-CoV-2 antibodies and forgoing health care. It is crucial to avoid delayed health care to prevent adverse health consequences.

PREVENTIVE MEDICINE (2021)

Add to Collection

Article Oncology

Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study

Mihir Gandhi et al.

Summary: The study revealed that the COVID-19 pandemic has significantly impacted the management of HCC among Asia-Pacific countries, leading to delays in diagnosis, changes in treatment modalities, and an increase in video/telephonic consultations. There were considerable variations in changes in HCC management among different countries.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)

Add to Collection

Article Gastroenterology & Hepatology

The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19

Isabel Campos-Varela et al.

Summary: Liver injury is common in patients with COVID-19, but mild damage usually does not impact severe clinical outcomes significantly. Elevated AST levels at admission are a strong predictor of ICU admission and/or death, especially in patients over 65 years old.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area

Giuliana Amaddeo et al.

Summary: During the COVID-19 pandemic in 2020, there were fewer patients with hepatocellular carcinoma in the metropolitan area of Paris, with similar rates of treatment modification but significantly longer treatment delays compared to 2019.

JHEP REPORTS (2021)

Add to Collection

Letter Gastroenterology & Hepatology

COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy

Alessio Aghemo et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care

Elliot B. Tapper et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Review Gastroenterology & Hepatology

Liver injury during highly pathogenic human coronavirus infections

Ling Xu et al.

LIVER INTERNATIONAL (2020)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Implications of COVID-19 for patients with pre-existing digestive diseases

Ren Mao et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Liver injury in COVID-19: management and challenges

Chao Zhang et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Editorial Material Gastroenterology & Hepatology

What Should Gastroenterologists and Patients Know About COVID-19?

Ryan C. Ungaro et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Shiv Kumar Sarin et al.

HEPATOLOGY INTERNATIONAL (2020)

Add to Collection

Article Gastroenterology & Hepatology

Effect of COVID-19 on patients with compensated chronic liver diseases

Dong Ji et al.

HEPATOLOGY INTERNATIONAL (2020)

Add to Collection

Article Gastroenterology & Hepatology

High rates of 30-day mortality in patients with cirrhosis and COVID-19

Massimo Iavarone et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Editorial Material Gastroenterology & Hepatology

MAFLD in COVID-19 patients: an insidious enemy

Paola Dongiovanni et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Letter Gastroenterology & Hepatology

Cirrhosis management in a major referral center during COVID-19

Isabel Garrido et al.

JHEP REPORTS (2020)

Add to Collection

Review Gastroenterology & Hepatology

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

Tobias Boettler et al.

JHEP REPORTS (2020)

Add to Collection

Article Gastroenterology & Hepatology

COVID-19 and its effects on the digestive system and endoscopy practice

Enrik John T. Aguila et al.

JGH OPEN (2020)

Add to Collection

Article Gastroenterology & Hepatology

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

DE Kleiner et al.

HEPATOLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.